UK Asia Pacific Virtual Digital Health Mission

South Korea, Malaysia, Taiwan – 24 September 2020 onwards

Ten of the World’s most innovative digital health companies will be virtually visiting Korea, Malaysia and Taiwan

A wide range of fields are going to be showcased including:

  • Artificial Intelligence
  • Electronic Health Records
  • Remote Monitoring
  • Business Intelligence and Analytics
  • Specialist software

These UK companies will fit the needs of the Korean, Malaysian and Taiwanese markets.

The companies and their technologies:

Life Box

LifeBox Health transforms the surgical pathways within hospitals using digital technology. Successfully used in 10 UK hospitals, with 50000 patients, registered it continues to improve surgical services for hospitals. The digital tool has 3 key elements- a Secure Virtual Clinic (SVC), the LifeBox ePOA assessment app and an outcomes portal.

The SVC allows hospital staff to have video or audio consultations with patients. Importantly however patients can send staff key information- written, picture or video before, during or after the consultation. Likewise, hospitals can deliver information in the same way. The ePOA assessment app allows remote health assessment of patients prior to procedures together with video education. This reduces costs for hospitals, improves the quality of assessment and has high patient satisfaction.

The outcomes assessment module allows the collection of procedure satisfaction scores for the hospital. Together the 3 elements produce a complete end to end journey for the patient and hospital.

NextGate

Finding the same patient information across system and sites is critical for today’s customer expectations and business efficiency. For 15 years NextGate has enabled accurate data exchange and enterprise integration, sharing information on the same patient or provider. We help you see the healthcare journey from the patient or provider perspective.  Our award-winning EMPI and Provider Registry help you view a person’s experience across all touchpoints and create a comprehensive patient record and a care team mapping. Reduce duplicate records, trace a patient’s contacts, simplify registration and billing with an accurate understanding of the patient and caregivers encounters with each other. See how many global organizations have solved patient matching challenges with the industry-leading EMPI from NextGate.

TPP

TPP is a digital health company, committed to delivering world-class healthcare software around the world. Its EHR product, SystmOne, is used by over 7,000 NHS organisations in over 25 different care settings. This includes significant deployments in Acute Hospitals, Emergency Departments, Mental Health Services, Social Care services and General Practice. In recent years, TPP has increased its international presence, with live deployments in China, the Caribbean and across the Middle East.

By operating a centralised database of over 50 million unique EMRs/EHRs, TPP has become a leader in healthcare research and big data analytics. We have supported numerous high profile academic studies and are working on machine learning algorithms to implement back into our clinical systems.”

Diabetes Digital Media

Diabetes Digital Media (DDM) provide scalable, evidence-based, and clinically-proven digital health technologies (Software as a Medical Device) to over 1.8 million people in 6 languages. 

DDM provides localised behaviour change platforms to patients in the UK, Ireland, Germany, Switzerland, Mauritius, and most recently India in partnership with Samsung. 

DDM’s peer-reviewed architecture demonstrates significant patient health and economic benefits. Outcomes of DDM’s Gro Health platform include weight loss, up-to 70% reduction in prescribed medication, type 2 diabetes remission, and improvements in stress, anxiety and depression. Interventions are multi-platform and available on the web, iOS, Android, Apple Watch, Android Watch and Amazon smart speakers.

DDM works with over a dozen enterprise companies including Aviva, SwissRe and Novo Nordisk and is a Fellow to NHS Innovation Accelerator, Royal College of GP’s Innovation Programme

Concentric Health

At Concentric Health our mission is to transform how decisions are made about our health. Decisions informed by patent outcomes and shared by patent and clinician.

Concentric is a digital consent and shared decision-making application which transforms the paper process of giving consent for treatment. With Concentric, facilitate better consent conversions, offer remote consent, and share standardised, lay-friendly, accessible information that is made bespoke for each individual.

Concentric is used across leading UK healthcare institutions such as Imperial College Healthcare NHS Trust and the Chelsea and Westminster Hospital NHS Trust and is seen as a key element in organisational COVID recovery, reducing medico-legal risk, and delivering excellence in patient experience.

Trustedoctor

Trustedoctor is an end-to-end virtual care platform and the global network of leading doctors/hospitals in specialized healthcare. The platform and the network is being offered as a digitized virtual care service to critical illness insurance and employee benefit schemes. The service includes video second opinions and virtual consultations with live-imaging as well as other customizable products addressing the healthcare navigation needs for complex, chronic or life-threatening conditions. 

We simplify access to specialized healthcare around the world for patients, policyholders or employees in chronic conditions including cancer and cardiology.

Trustedoctor provides the platform technology and navigation service for medical providers (doctors and hospitals) and virtual care products to critical illness insurance companies and international corporates.

Datapharm

Datapharm was formed in 1977 to publish medicines information on behalf of the pharmaceutical industry. In 1999 we launched emc (electronic medicines compendium) which has become the UK’s most comprehensive, trusted and accessible source of information about medicines. We use the best digital platforms to improve the accessibility and usefulness of medicines information to our rapidly growing audience of over 70 million visitors per year.  Our customers and audiences trust us to deliver up-to-date, accurate and reliable medical information.

We partner with a wide range of professional and voluntary health organisations to improve health literacy and decision making about medicines for patients, carers, healthcare professionals and the pharmaceutical industry. These organisations include the NHS, the Medicines and Healthcare products Regulatory Agency, European Medicines Agency, the Department of Health & Social Care, the Association of the British Pharmaceutical Industry and the British Generic Manufacturers Association. 

Elsevier

Discoveries unimaginable a generation ago are uncovered every day. At Elsevier, we recognize the potential for scientists and clinicians to find new answers, reshape human knowledge and tackle the most urgent global crises.

We want to make analysis easier for everyone working in science and medicine, enabling them to manage their work more efficiently and spend more time making breakthroughs. That’s why Elsevier is evolving. Growing from our roots in publishing, we’re creating analytical solutions to serve the needs of science and health.

C2-Ai

C2-Ai provides globally unique Ai-backed systems that help hospitals to demonstrably reduce avoidable harm, mortality, and clinical variation.  We do this while generating significant savings on operating expenditure (potentially USD millions per hospital) and reducing complaints/clinical negligence claims by up to 10%.

We have the world’s only, accurate, risk-adjusted picture of hospital performance in managing COVID patients as well as helping key avoidable conditions acquired in hospital that block beds needed during the pandemix. Per hospital, this has been shown to provide savings of 500 lives per annum, $9m and frees up 1,000 bed-days per month. Across the US this would be 350,000 lives and $12.5bn of in-year savings.

We can also triage the non-urgent surgical waiting list, providing the objective priority scoring demanded by the CDC with our COMPASS system that assesses the individualised risk of mortality and complications based on operative type and patient physiology.

Spirit Health

Spirit has 25 years of technology pedigree and over a decade of experience delivering sustainable technology solutions and services across the health and care continuum. Our medicines optimisation programmes, high quality primary care provision, market-leading digital health services and healthcare pathway services have all received high acclaim.

We provide CliniTouch Vie, an enhanced remote patient monitoring system, that offers advanced warning of potential condition deterioration alongside pre-emptive intervention data and real-time location-based satellite air quality data. This means our combined technology and service provision can improve the outcomes of patients with chronic conditions e.g. Diabetes, Chronic Obstructive Pulmonary Disease, Heart failure, etc. and provides value on specific interventions for managing their conditions safely at home.

Our partnership approach has enabled our digital technology to be part of clinical pathways that facilitate earlier discharge, prevent readmissions, reduce risk of future exacerbations, and improve self-management, whilst maximising clinical capacity.

We welcome you to attend the main pitching webinar on the 24th September bringing together these UK companies with partners from the public and private sector in the region. Additionally, between 25th September to 9th October, we can organise B2B one to one meetings with you and these ten companies.

The Event Details:

Date: 24 September onwards

Key events:

  • 24 September: Pitching event 09.00 BST United Kingdom, 16.00 MYT Malaysia, 16:00 CST Taiwan, 17.00 KST Korea
  • 25 September onwards: B2Bs Upon request

Location: Webinar virtual

Audience: Companies, investors and government departments across South Korea, Malaysia, and Taiwan

CLICK TO REGISTER INTEREST